Cargando…

Neuroprotection of the hypoxic-ischemic mouse brain by human CD117(+)CD90(+)CD105(+) amniotic fluid stem cells

Human amniotic fluid contains two morphologically-distinct sub-populations of stem cells with regenerative potential, spindle-shaped (SS-hAFSCs) and round-shaped human amniotic fluid stem cells (RS-hAFSCs). However, it is unclear whether morphological differences correlate with functionality, and th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corcelli, Michelangelo, Hawkins, Kate, Vlahova, Filipa, Hunjan, Avina, Dowding, Kate, De Coppi, Paolo, David, Anna L., Peebles, Donald, Gressens, Pierre, Hagberg, Henrik, Hristova, Mariya, Guillot, Pascale V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799160/ https://www.ncbi.nlm.nih.gov/pubmed/29402914 http://dx.doi.org/10.1038/s41598-018-20710-9

Ejemplares similares

Embryonic Stem Cell‐Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic‐Ischemic Mouse Brain
por: Hawkins, Kate E., et al.
Publicado: (2018)

TGFβ-induced osteogenic potential of human amniotic fluid stem cells via CD73-generated adenosine production
por: Hau, Kwan-Leong, et al.
Publicado: (2017)

Differentiation of CD117(+) Amniotic Fluid Stem Cells towards Nephron Progenitors
por: Jabeen, Hina, et al.
Publicado: (2022)

Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A
por: Vlahova, Filipa, et al.
Publicado: (2019)

Publisher Correction: Human mid-trimester amniotic fluid (stem) cells lack expression of the pluripotency marker OCT4A
por: Vlahova, Filipa, et al.
Publicado: (2020)

Cloned, CD117 Selected Human Amniotic Fluid Stem Cells Are Capable of Modulating the Immune Response
por: Moorefield, Emily C., et al.
Publicado: (2011)

CD105(+)CD90(+)CD13(+) identifies a clonogenic subset of adventitial lung fibroblasts
por: Kadefors, Måns, et al.
Publicado: (2021)

Formation of $^{117}In-H$ pairs after annealing of GaN implanted with $^{117}Cd(^{117}In)$
por: Dietrich, M, et al.
Publicado: (2001)

Expression of CD81 and CD117 in plasma cell myeloma and the relationship to prognosis
por: Chen, Fang, et al.
Publicado: (2018)

Expression of endoglin (CD105) in cervical cancer
por: Zijlmans, H J, et al.
Publicado: (2009)

The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemia
por: Tran, Vinh Thanh, et al.
Publicado: (2020)

Amniotic-Fluid Stem Cells: Growth Dynamics and Differentiation Potential after a CD-117-Based Selection Procedure
por: Arnhold, S., et al.
Publicado: (2011)

An Immunohistochemical Survey to Evaluate the Expression of CD105 and CD34 in Ameloblastoma and Odontogenic Keratocyst
por: Jamshidi, Shokoofeh, et al.
Publicado: (2014)

Immunohistochemical Comparison of the Expression of CD34 and CD105 in Odontogenic Keratocyst and Dentigerous Cyst
por: Jamshidi, Shokoofeh, et al.
Publicado: (2017)

The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients
por: Ceran, Funda, et al.
Publicado: (2017)

Role of CD135/CD117 on Prognosis and Overall Survival of Acute Myeloid Leukemia
por: Raeisi, Mortaza, et al.
Publicado: (2019)

Immunoexpression of CD34, CD117, and p53 in Hypocellular Bone Marrow Disorders
por: Sharma, Pooja, et al.
Publicado: (2021)

Phenotypic Characterization of Adherent Cells Population CD34+ CD90+ CD105+ Derived from Wharton’s Jelly
por: Walecka, Irena, et al.
Publicado: (2017)

Different culture method changing CD105 expression in amniotic fluid MSCs without affecting differentiation ability or immune function
por: Wang, Ding, et al.
Publicado: (2020)

Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
por: Di Paolo, Virginia, et al.
Publicado: (2018)

CD105 (Endoglin) as negative prognostic factor in AML
por: Kauer, Joseph, et al.
Publicado: (2019)

PROGNOSTIC ROLE OF CD44 EXPRESSION AND NEOVASCULARIZATION DETERMINED BY ENDOGLIN (CD105) IN GLIOBLASTOMA PATIENTS
por: Mihić, Josip, et al.
Publicado: (2019)

CD44+/CD105+ Human Amniotic Fluid Mesenchymal Stem Cells Survive and Proliferate in the Ovary Long-Term in a Mouse Model of Chemotherapy-Induced Premature Ovarian Failure
por: Liu, Te, et al.
Publicado: (2012)

Levels of CD105(+) cells increase and cell proliferation decreases during S-phase arrest of amniotic fluid cells in long-term culture
por: WANG, DING, et al.
Publicado: (2014)

The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia
por: Gu, Runxia, et al.
Publicado: (2017)

Osteogenic Potential of Mouse Adipose-Derived Stem Cells Sorted for CD90 and CD105 In Vitro
por: Yamamoto, Maiko, et al.
Publicado: (2014)

Evaluation of microvessel density with CD31 and CD105 in patients with psoriasis under methotrexate and acitretin therapy
por: Zemheri, Ebru, et al.
Publicado: (2020)

CD34 and CD105 Microvessels in Resected Bone Specimen May Implicate Wound Healing in MRONJ
por: Marcianò, Antonia, et al.
Publicado: (2021)

Expression and clinical significance of CD31, CD34, and CD105 in pulmonary ground glass nodules with different vascular manifestations on CT
por: Guo, Chen-ran, et al.
Publicado: (2022)

Counteracting bone fragility with human amniotic mesenchymal stem cells
por: Ranzoni, Anna M., et al.
Publicado: (2016)

Antagonizing CD105 enhances radiation sensitivity in prostate cancer
por: Madhav, Anisha, et al.
Publicado: (2018)

Identification of CD105 (endoglin) as novel risk marker in CLL
por: Greiner, Sarah M., et al.
Publicado: (2022)

Evaluation of the Expression of C-kit (CD117) in Ependymomas and Oligodendrogliomas
por: Zavalhia, Lisiane Silveira, et al.
Publicado: (2012)

CD117(+) cells in the circulation are predictive of advanced prostate cancer
por: Kerr, Bethany A., et al.
Publicado: (2014)

Immunohistochemical evaluation of CD117 in mast cell of aggressive periodontitis
por: Mazreah, Siavash Azizi, et al.
Publicado: (2020)

Immunohistochemical study of CD117 in various cutaneous melanocytic lesions
por: Radu, Antonia, et al.
Publicado: (2021)

CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34
por: Miyata, Yasuyoshi, et al.
Publicado: (2013)

The CD105:CD106 microparticle ratio is CD106 dominant in polycystic ovary syndrome compared to type 2 diabetes and healthy subjects
por: Al-Qaissi, Ahmed, et al.
Publicado: (2019)

Expression of CK19, CD105 and CD146 are associated with early metastasis in patients with renal cell carcinoma
por: Yang, Xiaojie, et al.
Publicado: (2018)

Histomorphological and Morphometric Evaluation of Microvessel Density in Nodal Non-Hodgkin Lymphoma Using CD34 and CD105
por: Kataria, Sant Prakash, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5g97sgf1p9bl9sdf5illchcga3